Doylestown, PA, United States of America

Reb J Russell



 

Average Co-Inventor Count = 19.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2019-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Reb J Russell

Introduction

Reb J Russell is a notable inventor based in Doylestown, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compositions and methods for producing recombinant proteins. With a total of 5 patents to his name, Russell's work has had a considerable impact on medical research and therapeutic applications.

Latest Patents

Russell's latest patents include innovative methods for producing CTLA4-Ig, a protein that plays a crucial role in immune regulation. One of his inventions provides mammalian cells capable of producing recombinant CTLA4-Ig and its variants. This invention also encompasses compositions comprising CTLA4-Ig and formulations thereof. Furthermore, he has developed methods for mass-producing CTLA4-Ig from these mammalian cells and for purifying the CTLA4-Ig, which is essential for therapeutic use.

Career Highlights

Throughout his career, Reb J Russell has been associated with Bristol-Myers Squibb Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of recombinant proteins in medicine.

Collaborations

Russell has collaborated with several esteemed colleagues, including Kirk J Leister and Eugene J Schaefer. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Reb J Russell's contributions to biotechnology and his innovative patents reflect his dedication to advancing medical science. His work continues to influence the development of therapeutic proteins, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…